MedTrace Logo

GlideScope With EGRI Assessment in Obese Patients

NCT02188979 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 195

Last updated 2014-07-14

No results posted yet for this study

Summary

BACKGROUND Unpredicted difficult tracheal intubation (DTI) with Macintosh laryngoscopy occurs frequently in obese patients. We investigated the incidence of DTI using the GlideScope® videolaryngoscope (GVL) with an algorithm based on a pre-operative assessment with the El Ganzouri Risk Index (EGRI).

METHODS We prospectively enrolled morbidly obese patients (BMI\>40 kg/m2) undergoing abdominal surgery. Patients were scheduled for flexible fibre optic bronchoscopic intubation (FFBI) or GVL intubation if the EGRI score was ≥7 or \<7, respectively. The primary outcome was the occurrence of DTI that was defined as Cormack and Lehane (C\&L) grades ≥III, Intubation Difficulty Scale (IDS)\>5 and modified IDS (mIDS)\>5. A numeric rating scale (NRS) was also used. Secondary outcomes included intubation success during the first attempt, the time to Cormack (TTC), the time to intubation (TTI), failure to intubate, oxygen desaturation and difficult ventilation.

Conditions

  • Morbid Obesity

Sponsors & Collaborators

  • Università degli Studi di Brescia

    lead OTHER

Principal Investigators

  • Alessandro Mosca, MD · Università degli Studi di Brescia

  • Elena Cagnazzi, MD · Università degli Studi di Brescia

  • Federico Pe, MD · Università degli Studi di Brescia

  • Tiziana Togazzari, MD · Universitry of Brescia

  • Ottavia Manenti, MD · Univertsity of Brescia

  • Francesco Mittempergher, MD · Università degli Studi di Brescia

  • Elena Raffetti, MD · Università degli Studi di Brescia

  • Francesco Donato, Professor · Università degli Studi di Brescia

  • Nicola Latronico, Professor · Università degli Studi di Brescia

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2014-04-30
Completion
2014-04-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02188979 on ClinicalTrials.gov